Comanche Biopharma

Developer of a biopharmaceutical company intended to develop an investigational siRNA medicine for preterm preeclampsia. The company provides access to safe and effective therapies for treating life-threatening complications of pregnancy, and those solutions must be evidence-based and affordable, enabling women to avail of cost-effective and sustainable preeclampsia treatment at its root cause.

New Enterprise Associates

🏥 Healthcare